Use of imexon as an immune suppressive and pharmaceutical compositions containing imexon

US5369119A · kind A · utility

Assignee

• Boehringer Mannheim GmbH · DE

Inventors

• Dieter Herrmann · Kirchzarten, DE
• Rainer Haag · Berlin, DE
• Elmar Bosies · Weinheim, DE
• Uwe Bicker · Mannheim, DE
• Wolfgang Kampe

Key dates

• Filing date: Mar 2, 1993
• Grant date: Nov 29, 1994
• Expiry date: Mar 2, 2013

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K31/505
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The subject of the present invention is the use of imexon for the production of pharmaceutical compositions with an immunosuppressive action. The present invention also provides pharmaceutical compositions containing imexon and further active materials.